Metsera, Inc. (NASDAQ:MTSR - Get Free Report)'s stock price fell 4.8% during trading on Tuesday . The stock traded as low as $25.62 and last traded at $25.91. 125,837 shares were traded during trading, a decline of 81% from the average session volume of 650,358 shares. The stock had previously closed at $27.22.
Analysts Set New Price Targets
Several equities analysts have recently weighed in on the company. Evercore ISI started coverage on Metsera in a research report on Tuesday, February 25th. They issued an "outperform" rating on the stock. Bank of America began coverage on Metsera in a report on Tuesday, February 25th. They issued a "buy" rating and a $38.00 price objective on the stock. Guggenheim assumed coverage on shares of Metsera in a report on Tuesday, February 25th. They set a "buy" rating and a $56.00 target price for the company. Finally, Cantor Fitzgerald began coverage on shares of Metsera in a research note on Tuesday, February 25th. They issued an "overweight" rating on the stock.
Get Our Latest Report on MTSR
Metsera Stock Performance
Metsera (NASDAQ:MTSR - Get Free Report) last issued its earnings results on Wednesday, March 26th. The company reported ($3.52) earnings per share (EPS) for the quarter.
About Metsera
(
Get Free Report)
Metsera, Inc is a clinical stage biopharmaceutical company, which engages in the development of a next-generation injectable and oral nutrient stimulated hormone, or NuSH, analog peptides to treat obesity, overweight and related conditions. Its product pipeline includes MET-097i, MET-233, and MET-224o.
Further Reading
Before you consider Metsera, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Metsera wasn't on the list.
While Metsera currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
